| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 674,033 | 570,589 | 505,539 | 666,728 | | Cost of Revenue | 482,614 | 433,352 | 412,143 | 490,656 | | | Gross Profit | 191,419 | 137,237 | 93,396 | 176,072 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 145,628 | 136,668 | 139,071 | 144,612 | | Non Recurring | 55,894 | 216,627 | 44,344 | 132,922 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (10,103) | (216,058) | (90,019) | (101,462) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 3,484 | 769 | 3,510 | 19,229 | | Earnings Before Interest And Taxes | (6,610) | (215,289) | (86,509) | (82,233) | | Interest Expense | 1,000 |
-
|
-
|
-
| | Income Before Tax | (7,610) | (215,289) | (86,509) | (82,233) | | Income Tax Expense | 3,976 | 4,451 | (27,909) | 5,011 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (11,595) | (219,740) | (58,600) | (87,244) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (11,595) | (219,740) | (58,600) | (87,244) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($11,595) | ($219,740) | ($58,600) | ($87,244) |
|
0.22% Nasdaq 
Income Statement
